GTX falls in early drug-stock trading
March 02, 2011 at 11:06 AM EST
GTX shares were falling on news that it has ended its pact with Ipsen to commercialize its bone drug toremifene.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.